对凡德他尼的严重光敏反应。 - Suppr

Suppr

超能文献

Severe photosensitivity reaction to vandetanib.

作者信息

Chang Chih-Hsiang, Chang John W C, Hui Chung-Yee, Yang Chih-Hsun

机构信息

Department of Dermatology, Chang Gung Memorial Hospital and University, Taipei, Taiwan.

出版信息

J Clin Oncol. 2009 Sep 20;27(27):e114-5. doi: 10.1200/JCO.2009.21.8479. Epub 2009 Jun 29.

DOI:10.1200/JCO.2009.21.8479

PMID:19564539

Abstract

摘要

相似文献

Severe photosensitivity reaction to vandetanib.

J Clin Oncol. 2009 Sep 20;27(27):e114-5. doi: 10.1200/JCO.2009.21.8479. Epub 2009 Jun 29.

A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib.

Arch Dermatol. 2012 Dec;148(12):1418-20. doi: 10.1001/2013.jamadermatol.192.

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.

J Clin Oncol. 2010 Feb 10;28(5):767-72. doi: 10.1200/JCO.2009.23.6604. Epub 2010 Jan 11.

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer.

Endocr Relat Cancer. 2019 Feb 1;26(2):241-250. doi: 10.1530/ERC-18-0258.

Vandetanib for the treatment of medullary thyroid cancer.

Clin Cancer Res. 2013 Feb 1;19(3):524-9. doi: 10.1158/1078-0432.CCR-12-2353. Epub 2012 Dec 11.

Pharmacokinetics of vandetanib: three phase I studies in healthy subjects.

Clin Ther. 2012 Jan;34(1):221-37. doi: 10.1016/j.clinthera.2011.11.011. Epub 2011 Dec 28.

Diffuse interstitial lung disease linked to vandetanib.

Clin Lung Cancer. 2012 May;13(3):236-8. doi: 10.1016/j.cllc.2011.10.004. Epub 2011 Dec 1.

Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib.

Ann Oncol. 2007 Sep;18(9):1582-3. doi: 10.1093/annonc/mdm420.

[Molecular therapy for HCC?].

Z Gastroenterol. 2006 Feb;44(2):205-6. doi: 10.1055/s-2005-859031.

Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study.

J Hepatol. 2012 May;56(5):1097-1103. doi: 10.1016/j.jhep.2011.12.013. Epub 2012 Jan 13.

引用本文的文献

DFT Structural and UV-Vis Spectral Insights into Photosensitivity of Vandetanib: A Dual EGFR/SARS-CoV-2 Mpro Inhibitor.

Pharmaceuticals (Basel). 2025 Aug 29;18(9):1297. doi: 10.3390/ph18091297.

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis.

An Bras Dermatol. 2022 Jan-Feb;97(1):127-128. doi: 10.1016/j.abd.2021.05.010. Epub 2021 Nov 19.

Vandetanib-induced Phototoxic Drug Eruption Treated with Extract: A Case Report and Review of the Literature.

J Clin Aesthet Dermatol. 2019 Oct;12(10):35-38. Epub 2019 Oct 1.

A rare cutaneous phototoxic rash after vandetanib therapy in a patient with thyroid cancer: A case report.

Medicine (Baltimore). 2019 Aug;98(31):e16392. doi: 10.1097/MD.0000000000016392.

Drug-Induced Photosensitivity-An Update: Culprit Drugs, Prevention and Management.

Drug Saf. 2019 Jul;42(7):827-847. doi: 10.1007/s40264-019-00806-5.

Phototoxic Reaction Induced by Pazopanib.

Case Rep Dermatol. 2018 Nov 21;10(3):251-256. doi: 10.1159/000494611. eCollection 2018 Sep-Dec.

Development of Photoonycholysis with Vandetanib Therapy.

Skin Appendage Disord. 2017 Jan;2(3-4):146-151. doi: 10.1159/000452425. Epub 2016 Nov 3.

A rare case of late-onset lichenoid photodermatitis after vandetanib therapy.

JAAD Case Rep. 2015 May 25;1(3):141-3. doi: 10.1016/j.jdcr.2015.03.008. eCollection 2015 May.

Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report.

BMC Dermatol. 2015 Feb 13;15:2. doi: 10.1186/s12895-015-0022-1.

Drug-induced photosensitivity: culprit drugs, management and prevention.

Drug Saf. 2011 Oct 1;34(10):821-37. doi: 10.2165/11592780-000000000-00000.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Severe photosensitivity reaction to vandetanib.

J Clin Oncol. 2009 Sep 20;27(27):e114-5. doi: 10.1200/JCO.2009.21.8479. Epub 2009 Jun 29.

A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib.

Arch Dermatol. 2012 Dec;148(12):1418-20. doi: 10.1001/2013.jamadermatol.192.

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.

J Clin Oncol. 2010 Feb 10;28(5):767-72. doi: 10.1200/JCO.2009.23.6604. Epub 2010 Jan 11.

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer.

Endocr Relat Cancer. 2019 Feb 1;26(2):241-250. doi: 10.1530/ERC-18-0258.

Vandetanib for the treatment of medullary thyroid cancer.

Clin Cancer Res. 2013 Feb 1;19(3):524-9. doi: 10.1158/1078-0432.CCR-12-2353. Epub 2012 Dec 11.

Pharmacokinetics of vandetanib: three phase I studies in healthy subjects.

Clin Ther. 2012 Jan;34(1):221-37. doi: 10.1016/j.clinthera.2011.11.011. Epub 2011 Dec 28.

Diffuse interstitial lung disease linked to vandetanib.

Clin Lung Cancer. 2012 May;13(3):236-8. doi: 10.1016/j.cllc.2011.10.004. Epub 2011 Dec 1.

Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib.

Ann Oncol. 2007 Sep;18(9):1582-3. doi: 10.1093/annonc/mdm420.

[Molecular therapy for HCC?].

Z Gastroenterol. 2006 Feb;44(2):205-6. doi: 10.1055/s-2005-859031.

Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study.

J Hepatol. 2012 May;56(5):1097-1103. doi: 10.1016/j.jhep.2011.12.013. Epub 2012 Jan 13.

引用本文的文献

DFT Structural and UV-Vis Spectral Insights into Photosensitivity of Vandetanib: A Dual EGFR/SARS-CoV-2 Mpro Inhibitor.

Pharmaceuticals (Basel). 2025 Aug 29;18(9):1297. doi: 10.3390/ph18091297.

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis.

An Bras Dermatol. 2022 Jan-Feb;97(1):127-128. doi: 10.1016/j.abd.2021.05.010. Epub 2021 Nov 19.

Vandetanib-induced Phototoxic Drug Eruption Treated with Extract: A Case Report and Review of the Literature.

J Clin Aesthet Dermatol. 2019 Oct;12(10):35-38. Epub 2019 Oct 1.

A rare cutaneous phototoxic rash after vandetanib therapy in a patient with thyroid cancer: A case report.

Medicine (Baltimore). 2019 Aug;98(31):e16392. doi: 10.1097/MD.0000000000016392.

Drug-Induced Photosensitivity-An Update: Culprit Drugs, Prevention and Management.

Drug Saf. 2019 Jul;42(7):827-847. doi: 10.1007/s40264-019-00806-5.

Phototoxic Reaction Induced by Pazopanib.

Case Rep Dermatol. 2018 Nov 21;10(3):251-256. doi: 10.1159/000494611. eCollection 2018 Sep-Dec.

Development of Photoonycholysis with Vandetanib Therapy.

Skin Appendage Disord. 2017 Jan;2(3-4):146-151. doi: 10.1159/000452425. Epub 2016 Nov 3.

A rare case of late-onset lichenoid photodermatitis after vandetanib therapy.

JAAD Case Rep. 2015 May 25;1(3):141-3. doi: 10.1016/j.jdcr.2015.03.008. eCollection 2015 May.

Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report.

BMC Dermatol. 2015 Feb 13;15:2. doi: 10.1186/s12895-015-0022-1.

Drug-induced photosensitivity: culprit drugs, management and prevention.

Drug Saf. 2011 Oct 1;34(10):821-37. doi: 10.2165/11592780-000000000-00000.